Bipolar Disorder Treatment
Bipolar Disorder
Resources
Basic Information
Introduction to Bipolar DisorderTypes of Bipolar and Similar DisordersCurrent Understandings and Body SystemsDiagnosis of Bipolar DisorderMedication Treatments for Bipolar DisorderPsychotherapy and Other TreatmentsSelf-Help and Helping OthersReferences and Reading List
More InformationTestsLatest NewsQuestions and AnswersBlog EntriesVideosLinksBook ReviewsSelf-Help Groups
Community

Talk about this issue in our mental health support community

Therapist Search
Find a Therapist:
 (USA/CAN only)

Use our Advanced Search to locate a therapist outside of North America.

Related Topics

Depression: Major Depression & Unipolar Varieties
Suicide
Addictions: Alcohol and Substance Abuse
View the Depression Primer - an illustrated book about Depression

Risperdal Consta Approved for Bipolar Disorder

(HealthDay News)
by -- Scott Roberts
Updated: May 18th 2009

MONDAY, May 18 (HealthDay News) -- The Janssen Pharmaceuticals drug Risperdal Consta (risperidone) has been approved by the U.S. Food and Drug Administration for people with Bipolar 1 disorder, the drug maker said Monday.

Risperdal Consta is the long-acting version of Risperdal, which was first FDA-approved more than a decade ago and is now sanctioned for Bipolar 1, schizophrenia and autism.

Type 1 bipolar disorder involves at least one manic episode, with or without a major depressive episode.

Approval of Risperdal Consta for Bipolar 1 was granted as a single therapy, or in combination with lithium or valproate, Janssen said in a news release.

As with similar antipsychotic drugs, the packaging for Risperdal Consta includes a warning that the drug is not approved for elderly people with dementia-related psychosis, and could increase their risk of death.

More information

The FDA has more about this drug's approval history.

Follow us on Twitter!

Find us on Facebook!





powered by centersite dot net